Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Plant Biotechnology Journal

• Publication date

  2008-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1467-7652.2008.00330.xPMID 18346095
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Aberrant localization and underglycosylation of highly accumulating single-chain Fv-Fc antibodies in transgenic Arabidopsis seeds

  2007cited by this paper
• Production of a monoclonal antibody in plants with a humanized N-glycosylation pattern.

  2007cited by this paper
• A Unique β1,3-Galactosyltransferase Is Indispensable for the Biosynthesis of N-Glycans Containing Lewis a Structures in Arabidopsis thaliana[W][OA]

  2007cited by this paper
• In vivo glyco‐engineered antibody with improved lytic potential produced by an innovative non‐mammalian expression system

  2007cited by this paper
• Functional analysis of the broadly neutralizing human anti‐HIV‐1 antibody 2F5 produced in transgenic BY‐2 suspension cultures

  2007cited by this paper
• Molecular cloning and heterologous expression of beta1,2-xylosyltransferase and core alpha1,3-fucosyltransferase from maize.

  2006cited by this paper
• Glycan optimization of a human monoclonal antibody in the aquatic plant Lemna minor

  2006cited by this paper
• The Role of Protein Glycosylation in Allergy

  2006cited by this paper
• The carbohydrate at FcgammaRIIIa Asn-162. An element required for high affinity binding to non-fucosylated IgG glycoforms.

  2006cited by this paper
• Rapid high-yield expression of full-size IgG antibodies in plants coinfected with noncompeting viral vectors

  2006cited by this paper
• Medicinal chemistry: Best of both worlds?

  2005cited by this paper
• Generation of Arabidopsis thaliana plants with complex N‐glycans lacking β1,2‐linked xylose and core α1,3‐linked fucose

  2004cited by this paper
• Unaltered complex N-glycan profiles in Nicotiana benthamiana despite drastic reduction of β1,2-N-acetylglucosaminyltransferase I activity

  2004cited by this paper
• In planta engineering of viral RNA replicons: efficient assembly by recombination of DNA modules delivered by Agrobacterium.

  2004cited by this paper
• Generation of Arabidopsis thaliana plants with complex N-glycans lacking beta1,2-linked xylose and core alpha1,3-linked fucose.

  2004cited by this paper
• Antibody production in transgenic plants.

  2004cited by this paper
• Monoclonal C5-1 antibody produced in transgenic alfalfa plants exhibits a N-glycosylation that is homogenous and suitable for glyco-engineering into human-compatible structures.

  2003cited by this paper
• The Absence of Fucose but Not the Presence of Galactose or Bisecting N-Acetylglucosamine of Human IgG1 Complex-type Oligosaccharides Shows the Critical Role of Enhancing Antibody-dependent Cellular Cytotoxicity*

  2003cited by this paper
• Lack of Fucose on Human IgG1 N-Linked Oligosaccharide Improves Binding to Human FcγRIII and Antibody-dependent Cellular Toxicity*

  2002cited by this paper
• A phase I trial with two human monoclonal antibodies (hMAb 2F5, 2G12) against HIV-1

  2002cited by this paper
• Plantibodies: applications, advantages and bottlenecks.

  2002cited by this paper
• Galactose-extended glycans of antibodies produced by transgenic plants

  2001cited by this paper
• High level accumulation of single-chain variable fragments in the cytosol of transgenic Petunia hybrida.

  1999cited by this paper
• N-Glycosylation of a mouse IgG expressed in transgenic tobacco plants.

  1999cited by this paper
• Structural analysis of N-glycans from allergenic grass, ragweed and tree pollens: Core α1,3-linked fucose and xylose present in all pollens examined

  1998cited by this paper
• Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1

  1996cited by this paper
• A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS

  1938cited by this paper

• Development of anti-dengue virus D8 neutralizing monoclonal antibody production in Nicotiana benthamiana.

  2026cites this paper
• Protective efficacy of a bivalent equine influenza H3N8 virus-like particle vaccine in horses.

  2025cites this paper
• Identification of β‐galactosidases along the secretory pathway of Nicotiana benthamiana that collectively hamper engineering of galactose‐extended glycans on recombinant glycoproteins

  2025influential citation
• Multiplex CRISPR/Cas9-mediated editing of seven glycosyltransferase homologs in Nicotiana benthamiana to produce stable, Cas9-free, glycoengineered plants

  2025cites this paper
• Highly efficient transgene‐free ErCas12a RNP‐protoplast genome editing and single‐cell regeneration in Nicotiana benthamiana for glyco‐engineering

  2025cites this paper
• Xyloglucan Endotransglycosylase/Hydrolase Downregulation Increases Nicotiana benthamiana Tolerance to Tobacco Mosaic Virus Infection

  2025cites this paper
• Reimagining biomanufacturing: scalable and safe plant-based systems for next-generation biopharmaceuticals

  2025cites this paper
• Plant-produced monoclonal antibodies recognize the native circumsporozoite protein on Plasmodium falciparum sporozoites

  2025cites this paper
• CRISPR/Cas9‐Mediated Knockouts of the ALG3 and GNTI in N. benthamiana and Their Application to Pharmaceutical Production

  2025cites this paper
• Advances and challenges in plant N-glycoengineering: when fucosylation matters

  2025cites this paper
• The plant platform for natural products synthesis: Tobacco

  2025cites this paper
• Complement therapeutic factor H-IgG proteins as pre-exposure prophylaxes against Lyme borreliae infections.

  2025cites this paper
• Improving the N-glycosylation occupancy of plant-produced IgG1 by engineering the amino acid environment at Asn297

  2025cites this paper
• Toward the commercialization of recombinant pharmaceuticals expressed in plants

  2025cites this paper
• An ACE2-Fc decoy produced in glycoengineered plants neutralizes ancestral and newly emerging SARS-CoV-2 variants and demonstrates therapeutic efficacy in hamsters

  2025cites this paper
• Posttranslational modifications of heterologous proteins expressed in Nicotiana benthamiana

  2025cites this paper
• Precision Glycoform Engineering: Combining plant and in vitro systems for tailored biopharmaceutical production

  2025cites this paper
• A comprehensive strategy for pandemic preparedness with neutralizing monoclonal antibodies

  2025cites this paper
• Plant production systems for recombinant immunotherapeutic proteins

  2025cites this paper
• Glycoengineering of plant-produced Pembrolizumab enhances FcRn binding and extends serum half-life in mice

  2025cites this paper
• Integrating molecular farming into sustainable plant biotechnology: a review of transgenic plants as biofactories for protein-based pharmaceutical production

  2025cites this paper
• A Kaleidoscope of Hosts: Expression Systems of Recombinant Antibody Reagents for Immunological Assays.

  2025cites this paper
• Light Chain Isotype and Antibody-Specificity Impact on Virus Neutralization

  2025cites this paper
• An engineered PD1-Fc fusion produced in N. benthamiana plants efficiently blocks PD1/PDL1 interaction

  2025cites this paper
• Engineering Nicotiana benthamiana for production of active cannabinoid synthases via secretory pathway optimization

  2024cites this paper
• Elucidation of the late steps in the glycan‐dependent ERAD of soluble misfolded glycoproteins

  2024cites this paper
• Implications of O-glycan modifications in the hinge region of a plant-produced SARS-CoV-2-IgA antibody on functionality

  2024influential citation
• The impact of N-glycans on the immune response of plant-produced SARS-CoV-2 RBD-Fc proteins

  2024cites this paper
• Immunogenic profile of a plant-produced nonavalent African horse sickness viral protein 2 (VP2) vaccine in IFNAR-/- mice

  2024cites this paper
• Complement therapeutic Factor H-IgG proteins as pre-exposure prophylaxes against Lyme borreliae infections

  2024cites this paper
• Enhancement of specialized metabolites using CRISPR/Cas gene editing technology in medicinal plants

  2024cites this paper
• IgG1 versus IgG3: influence of antibody-specificity and allotypic variance on virus neutralization efficacy

  2024influential citation
• Characterization of a plant-derived monoclonal antibody targeting extracellular enveloped virions of Monkeypox virus

  2024cites this paper
• Efficient Expression of Functionally Active Aflibercept with Designed N-glycans

  2024influential citation
• Production of therapeutic glycoproteins in glycoengineered plant: old farm for new crops.

  2024cites this paper
• N-Glycosylation of Plant Proteins

  2024cites this paper
• Platform-Specific Fc N-Glycan Profiles of an Antisperm Antibody

  2024cites this paper
• Stability Engineering of Recombinant Secretory IgA

  2024cites this paper
• Creating a novel engineered tobacco chassis with downregulated expression of β-1,2-xylosyltransferase

  2024cites this paper
• Recombinant neutralizing secretory IgA antibodies for preventing mucosal acquisition and transmission of SARS-CoV-2.

  2024cites this paper
• Enhanced efficacy of glycoengineered rice cell‐produced trastuzumab

  2024cites this paper
• β1,3-galactosyltransferase on chromosome 6 is essential for the formation of Lewis ^a structure on N-glycan in Oryza sativa

  2023cites this paper
• Producing Biologics with Defined N-Glycosylation in Plants.

  2023cites this paper
• The production of Newcastle disease virus-like particles in Nicotiana benthamiana as potential vaccines

  2023cites this paper
• Assessment of transient expression strategies to sialylate recombinant proteins in N. benthamiana.

  2023cites this paper
• Product safety aspects of plant molecular farming

  2023cites this paper
• A plant-produced SARS-CoV-2 spike protein elicits heterologous immunity in hamsters

  2023cites this paper
• Development of Antibody-Based Therapeutics Against West Nile Virus in Plants.

  2023cites this paper
• An oligosaccharyltransferase from Leishmania donovani increases the N-glycan occupancy on plant-produced IgG1

  2023cites this paper
• Effect of plant produced Anti-hIL-6 receptor antibody blockade on pSTAT3 expression in human peripheral blood mononuclear cells

  2023cites this paper
• Impact of mutations on the plant-based production of recombinant SARS-CoV-2 RBDs

  2023cites this paper
• Modulating antibody effector functions by Fc glycoengineering.

  2023cites this paper
• Plant glycoengineering for designing next-generation vaccines and therapeutic proteins.

  2023cites this paper
• A Dual-Approach Strategy to Optimize the Safety and Efficacy of Anti-Zika Virus Monoclonal Antibody Therapeutics

  2023cites this paper
• Scaling eukaryotic cell‐free protein synthesis achieved with the versatile and high‐yielding tobacco BY‐2 cell lysate

  2023cites this paper
• Plant-based biopharmaceutical engineering

  2023cites this paper
• Therapeutic efficacy of plant-produced Nivolumab in transgenic C57BL/6-hPD-1 mouse implanted with MC38 colon cancer.

  2023cites this paper
• In planta deglycosylation improves the SARS-CoV-2 neutralization activity of recombinant ACE2-Fc

  2023cites this paper
• Optimization of infectious bronchitis virus-like particle expression in Nicotiana benthamiana as potential poultry vaccines

  2023cites this paper
• In planta expression of active bacterial GDP‐6‐deoxy‐d‐lyxo‐4‐hexulose reductase for glycan modulation

  2023influential citation
• The tobacco GNTI stem region harbors a strong motif for homomeric protein complex formation

  2023cites this paper
• Functional characterization of AF-04, an afucosylated anti-MARV GP antibody.

  2023cites this paper
• Plant‐derived Durvalumab variants show efficient PD‐1/PD‐L1 blockade and therapeutically favourable FcR binding

  2023influential citation
• Heterologous expression of fungal L-asparaginase: a systematic review.

  2023cites this paper
• Immunogenicity of adjuvanted plant-produced SARS-CoV-2 Beta spike VLP vaccine in New Zealand white rabbits

  2023cites this paper
• Plant-based production of a protective vaccine antigen against the bovine parasitic nematode Ostertagia ostertagi

  2023cites this paper
• Codon optimization regulates IgG3 and IgM expression and glycosylation in N. benthamiana

  2023cites this paper
• In vitro and in vivo studies of plant-produced Atezolizumab as a potential immunotherapeutic antibody

  2023cites this paper
• Improving the efficacy of plant-made anti-HIV monoclonal antibodies for clinical use

  2023influential citation
• Antitumor effect of plant-produced anti-CTLA-4 monoclonal antibody in a murine model of colon cancer

  2023cites this paper
• Efficacy of a plant-produced infectious bronchitis virus-like particle vaccine in specific pathogen-free chickens

  2023cites this paper
• The “humanized” N‐glycosylation pathway in CRISPR/Cas9‐edited Nicotiana benthamiana significantly enhances the immunogenicity of a S/preS1 Hepatitis B Virus antigen and the virus‐neutralizing antibody response in vaccinated mice

  2023cites this paper
• A genome‐edited N. benthamiana line for industrial‐scale production of recombinant glycoproteins with targeted N‐glycosylation

  2023cites this paper
• Dose immunogenicity study of a plant-produced influenza virus-like particle vaccine in layer hens

  2022cites this paper
• Nicotiana benthamiana Kunitz peptidase inhibitor-like protein involved in chloroplast-to-nucleus regulatory pathway in plant-virus interaction

  2022influential citation
• Expression of plant-produced anti-PD-L1 antibody with anoikis sensitizing activity in human lung cancer cells via., suppression on epithelial-mesenchymal transition

  2022cites this paper
• ALiCE®: A versatile, high yielding and scalable eukaryotic cell-free protein synthesis (CFPS) system

  2022cites this paper
• Reproducibility and flexibility of monoclonal antibody production with Nicotiana benthamiana

  2022cites this paper
• Antibody-dependent cellular cytotoxicity-null effector developed using mammalian and plant GlycoDelete platform

  2022cites this paper
• A novel plant‐made monoclonal antibody enhances the synergetic potency of an antibody cocktail against the SARS‐CoV‐2 Omicron variant

  2022cites this paper
• An optimized Factor H-Fc fusion protein against multidrug-resistant Neisseria gonorrhoeae

  2022cites this paper
• Engineering the N-glycosylation pathway of Nicotiana tabacum for molecular pharming using CRISPR/Cas9

  2022influential citation
• Production of the SARS-CoV-2 Spike protein and its Receptor Binding Domain in plant cell suspension cultures

  2022cites this paper
• Transient proteolysis reduction of Nicotiana benthamiana-produced CAP256 broadly neutralizing antibodies using CRISPR/Cas9

  2022influential citation
• Improving Protein Quantity and Quality—The Next Level of Plant Molecular Farming

  2022cites this paper
• Poly (ethylene) glycol (PEG) precipitation of glycosylated and non-glycosylated monoclonal antibodies

  2022cites this paper
• N-glycoproteins in Plant Cell Walls: A Survey

  2022cites this paper
• Investigation of the N-Glycosylation of the SARS-CoV-2 S Protein Contained in VLPs Produced in Nicotiana benthamiana

  2022cites this paper
• Preclinical evaluation of a plant-derived SARS-CoV-2 subunit vaccine: Protective efficacy, immunogenicity, safety, and toxicity

  2022cites this paper
• Impact of glycoengineering and immunogenicity on the anti-cancer activity of a plant-made lectin-Fc fusion protein

  2022cites this paper
• Production of Recombinant Proteins in Transgenic Tobacco Plants.

  2022cites this paper
• Augmenting glycosylation‐directed folding pathways enhances the fidelity of HIV Env immunogen production in plants

  2022influential citation
• Citrus sudden death-associated virus as a new expression vector for rapid in planta production of heterologous proteins, chimeric virions, and virus-like particles

  2022cites this paper
• Potential for a Plant-Made SARS-CoV-2 Neutralizing Monoclonal Antibody as a Synergetic Cocktail Component

  2022cites this paper
• Protective immunity of plant-produced African horse sickness virus serotype 5 chimaeric virus-like particles (VLPs) and viral protein 2 (VP2) vaccines in IFNAR-/- mice.

  2022cites this paper
• Transient Expression of Glycosylated SARS-CoV-2 Antigens in Nicotiana benthamiana

  2022cites this paper
• Recent Developments in Deciphering the Biological Role of Plant Complex N-Glycans

  2022cites this paper
• Glyco-Engineering Plants to Produce Helminth Glycoproteins as Prospective Biopharmaceuticals: Recent Advances, Challenges and Future Prospects

  2022cites this paper
• The potency and synergy of plant‐made monoclonal antibodies against the BA.5 variant of SARS‐CoV‐2

  2022cites this paper
• A Factor H-Fc fusion protein increases complement-mediated opsonophagocytosis and killing of community associated methicillin-resistant Staphylococcus aureus

  2022cites this paper